Cover Image
市場調查報告書

Astraea Therapeutics, LLC - 產品平台分析

Astraea Therapeutics, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 310065
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Astraea Therapeutics, LLC - 產品平台分析 Astraea Therapeutics, LLC - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 22 Pages
簡介

Astraea Therapeutics, LLC >是提供治療藥物成癮及中樞神經系統疾病用小分子治療藥的生物製藥公司。擁有為求發現治療中樞神經系統疾病的主要分子標的候補藥,優化研究開發平台的計劃。該公司目前正在研究分子標的,可望具有治療古柯鹼,酒精,尼古丁中毒的效果。

本報告提供Astraea Therapeutics, LLC的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Astraea Therapeutics, LLC的基本資料

Astraea Therapeutics, LLC概要

  • 主要資訊
  • 企業資料

Astraea Therapeutics, LLC:R&D概要

  • 主要的治療範圍

Astraea Therapeutics, LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Astraea Therapeutics, LLC:開發中產品概況

  • 初期階段產品開發中產品
    • 在前臨床階段的產品/聯合治療模式

Astraea Therapeutics, LLC:藥物簡介

  • AT-1001
  • Small Molecules to Activate NOP for Pain
  • Small Molecules to Inhibit Nicotinic Acetylcholine Receptor for Smoking Cessation

Astraea Therapeutics, LLC:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Astraea Therapeutics, LLC:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06947CDB

Summary

Global Markets Direct's, 'Astraea Therapeutics, LLC - Product Pipeline Review - 2015', provides an overview of the Astraea Therapeutics, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Astraea Therapeutics, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Astraea Therapeutics, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Astraea Therapeutics, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Astraea Therapeutics, LLC's pipeline products

Reasons to buy

  • Evaluate Astraea Therapeutics, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Astraea Therapeutics, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Astraea Therapeutics, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Astraea Therapeutics, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Astraea Therapeutics, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Astraea Therapeutics, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Astraea Therapeutics, LLC Snapshot
    • Astraea Therapeutics, LLC Overview
    • Key Information
    • Key Facts
  • Astraea Therapeutics, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Astraea Therapeutics, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Astraea Therapeutics, LLC - Pipeline Products Glance
    • Astraea Therapeutics, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Astraea Therapeutics, LLC - Drug Profiles
    • AT-1001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AT-127
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AT-326
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AT-403
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Agonize NOP for Pain and Alcohol Addiction
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Nicotinic Acetylcholine Receptor for Smoking Cessation
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Astraea Therapeutics, LLC - Pipeline Analysis
  • Astraea Therapeutics, LLC - Pipeline Products by Target
  • Astraea Therapeutics, LLC - Pipeline Products by Molecule Type
  • Astraea Therapeutics, LLC - Pipeline Products by Mechanism of Action
  • Astraea Therapeutics, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Astraea Therapeutics, LLC, Key Information
  • Astraea Therapeutics, LLC, Key Facts
  • Astraea Therapeutics, LLC - Pipeline by Indication, 2015
  • Astraea Therapeutics, LLC - Pipeline by Stage of Development, 2015
  • Astraea Therapeutics, LLC - Monotherapy Products in Pipeline, 2015
  • Astraea Therapeutics, LLC - Preclinical, 2015
  • Astraea Therapeutics, LLC - Discovery, 2015
  • Astraea Therapeutics, LLC - Pipeline by Target, 2015
  • Astraea Therapeutics, LLC - Pipeline by Molecule Type, 2015
  • Astraea Therapeutics, LLC - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Astraea Therapeutics, LLC - Pipeline by Top 10 Indication, 2015
  • Astraea Therapeutics, LLC - Pipeline by Stage of Development, 2015
  • Astraea Therapeutics, LLC - Monotherapy Products in Pipeline, 2015
  • Astraea Therapeutics, LLC - Pipeline by Top 10 Target, 2015
  • Astraea Therapeutics, LLC - Pipeline by Top 10 Molecule Type, 2015
  • Astraea Therapeutics, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top